Plunkett Research Online: Vernalis plc

VERNALIS PLC (VNLPY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vernalis plc discovers, researches and develops new compounds for central nervous system (CNS) disorders. The company focuses on treatment for pain, including the treatment of migraines; neurological disorders, such as Parkinson’s disease; cancer treatments; and inflammatory disease. The firm acti.....


VERNALIS PLC

Ticker: VNLPY
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 44 1189773133
Fax: 44 1189899300
Address: 100 Berkshire Place, Wharfedale Rd.
Berkshire, RG41 5RD United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Ian GarlandCEO
David MackneyCFO
See More
Vernalis plc discovers, researches and develops new compounds for central nervous system (CNS) disorders. The company focuses on treatment for pain, including the treatment of migraines; neurological disorders, such as Parkinson’s disease; cancer treatments; and inflammatory disease. The firm acti.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture